Overview
Chronic kidney disease (CKD) is a long-term, progressive condition in which the kidneys gradually lose their ability to filter waste and excess fluid from the blood, often advancing silently and benefiting greatly from preventive medicine and early intervention. CKD is a major public-health concern strongly linked to diabetes, hypertension, and other systemic conditions, and a key focus of preventive medicine because timely detection and risk-factor control can slow its progression and reduce complications. As kidney function declines, the body retains waste and fluid and develops disturbances in blood pressure, electrolytes, and red-blood-cell production, with consequences extending to cardiovascular and metabolic health. Preventive strategies emphasize screening, management of underlying conditions, and monitoring of kidney function to delay decline toward end-stage disease. Research collected here reflects these preventive and clinical themes, including thyroid function abnormalities in chronic and end-stage kidney disease, distinguishing depression from apathy in CKD, hypertension patterns by CKD stage, and the role of BCL-2 and BAK genes and hepcidin gene polymorphisms in CKD and hemodialysis patients. Additional studies address cardiovascular risk assessment such as Framingham risk scoring across populations, cardiorenal signaling in heart failure, mortality factors in patients with cancer and diabetes, the toxicity of iodinated radiographic contrast agents, and protective effects of natural compounds against nephrotoxicity, together illustrating CKD as a condition where prevention, risk management, and clinical care intersect.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Differentiating Depression from Apathy in Chronic Kidney Disease: A Prospective Study
Comparison of Dipper and Non-Dipper Hypertension Patterns According to Chronic Kidney Disease Stage
The Role of BCL-2 and BAK Genes in Chronic Kidney Disease and Haemodialysis Patients
Molecular Study of Hepcidin HAMP (-582A/G) Gene Polymorphisms and Measurement of Serum Hepcidin Level among Sudanese Patients with Anemia of Chronic Kidney Disease
Racial/Ethnic Differences in Framingham Risk Score in an NHANES Cohort
Cardiorenal Signaling Pathways in Heart Failure: Good and Bad News
Stratified Analysis of Factors Associated With Mortality in Patients With COVID-19 Based on Cancer and Diabetes
Morphological and Functional Abnormalities of the Thyroid Gland among End Stage Kidney Disease Patients
Protective Role of Quercetin Against Rotenone- Induced Hepato and Nephrotoxicity in Swiss Albino Mice
The Toxicity of Iodinated Radiographic Contrast Agents in the Clinical Practice
How this research is being cited
The 12 articles above have been cited 41 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Biomolecules
-
Rupam Saha et al. · 2025 · Medicine in Novel Technology and Devices
-
Ibrahim Halil Kenger et al. · 2025 · Journal of Applied Toxicology
-
Yuping Zhang et al. · 2025 · Biomaterials
-
2025 · BMC Nephrology
-
2025 · BMC Nephrology
-
2025 · Journal of Applied Toxicology
-
2025 · Biomaterials
A sample of recent works citing this journal's research on Chronic Kidney Disease, linking to each citing work.